GSK plc Cash And Cash Equivalents Held By Entity Unavailable For Use By Group
GSK plc (GLAXF) had Cash And Cash Equivalents Held By Entity Unavailable For Use By Group of GBP 247.00 million as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalentsHeldByEntityUnavailableForUseByGroup · last filed 2026-03-06
- 2025-12-31: Cash And Cash Equivalents Held By Entity Unavailable For Use By Group 247.00M GBP.
- 2024-12-31: Cash And Cash Equivalents Held By Entity Unavailable For Use By Group 177.00M GBP.
- 2023-12-31: Cash And Cash Equivalents Held By Entity Unavailable For Use By Group 190.00M GBP.
- 2022-12-31: Cash And Cash Equivalents Held By Entity Unavailable For Use By Group 200.00M GBP.
| Period end | Cash And Cash Equivalents Held By Entity Unavailable For Use By Group |
|---|---|
| 2025-12-31 | 247.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 177.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 190.00M GBP 20-F · filed 2025-03-03 |
| 2022-12-31 | 200.00M GBP 20-F · filed 2024-03-05 |
| 2021-12-31 | 200.00M GBP 20-F · filed 2023-03-10 |
| 2020-12-31 | 200.00M GBP 20-F · filed 2022-03-08 |
| 2019-12-31 | 200.00M GBP 20-F · filed 2021-03-12 |
| 2018-12-31 | 200.00M GBP 20-F · filed 2020-03-06 |
| 2017-12-31 | 800.00M GBP 20-F · filed 2019-03-15 |